LifeStance Health Group Announces Pricing of Secondary Public Offering

Core Viewpoint - LifeStance Health Group, Inc. has announced a secondary underwritten public offering of 20,000,000 shares of its common stock at a price of $6.25 per share, with the offering expected to close around May 24, 2024 [1][2]. Company Overview - LifeStance, founded in 2017, is one of the largest providers of virtual and in-person outpatient mental health care in the United States, employing approximately 6,800 mental health professionals and operating over 550 centers across 33 states [5]. - The company's mission is to enhance access to affordable and personalized mental healthcare for individuals experiencing various mental health conditions [5]. Offering Details - The offering is being conducted under a shelf registration statement filed with the SEC, and the selling stockholders will receive all proceeds from the offering, while the company itself will not receive any funds [1][3]. - The underwriters have a 30-day option to purchase an additional 3,000,000 shares from the selling stockholders [1]. - Major financial institutions involved in the offering include Morgan Stanley, Goldman Sachs & Co. LLC, and TPG Capital BD, LLC as lead book-runners, with Jefferies, UBS Investment Bank, and William Blair as joint book-runners [2].